Neil Herskowitz, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 5,000 shares at $5.83 ($29K) on 2019-06-18, disclosed to the SEC on 2019-06-19.
Open-market purchase of $29k ATXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.88 | 3,000 | $18K | 60.2% |
| 2 | $5.83 | 2,000 | $12K | 39.8% |
| Total | $5.86 avg | 5,000 | $29K | 100% |
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |